The Treatment of Chronic Myelogenous Leukemia in Blastic Crisis With the Chemotherapy Incorporating Vindesine-Prednisolone.

Tohoku Journal of Experimental Medicine - Japan
doi 10.1620/tjem.148.65
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Tohoku University Medical Press

Related search

Chronic Myelogenous Leukemia

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Complete Remission From Chronic Myelogenous Leukemia-Blastic Crisis Caused by Reduced Intensity Stem Cell Transplantation Following Partial Remission Due to Imatinib

Internal Medicine
Internal MedicineMedicine
2004English

Bosutinib in the Management of Chronic Myelogenous Leukemia

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Treatment of Resistant Chronic Myelogenous Leukemia With Ponatinib: One Centre Experience

Hematology & blood transfusion: interdepartamental collection
2016English

Chronic Myelogenous Leukemia Molecular Signature

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Erythroid Variant of Chronic Myelogenous Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Immunological Studies on Chronic Myelogenous Leukemia

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1976English

Thrombotic Thrombocytopenic Purpura in Chronic Myelogenous Leukemia

Canadian Journal of Ophthalmology
MedicineOphthalmology
2020English

Re-Evaluating the Role of BCR/ABL in Chronic Myelogenous Leukemia

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy